← Leaderboards
Beverly H Koller
Univ Of North Carolina Chapel Hill
$30,354,187
Attributed
$33,406,066
Total exposure
36
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,406,066 · 36
By mechanism
R01$20,314,595 · 13
R21$5,616,192 · 13
P01$2,441,660 · 2
U19$1,556,049 · 2
P50$1,014,071 · 2
RC1$1,000,000 · 1
Top collaborators
- Miroslav Styblo7 shared
- Jenny P.Y. Ting5 shared
- Delores Grant2 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesResponsePathway InteractionsCellsComplexInflammationPathogenesisProductionReceptorAllelesMouse ModelGeneticGenetic PolymorphismEmbryonic Stem CellMediatingStructureGene ExpressionIn VivoLaboratory MouseAsthmaBaseAnimalsCell LineGenerations
Grant awards (111)
Role and Mitigation of Inflammasomes and Inflammation During COVID-19$617,741
R01 · FY2025 · AI
Humanized mouse models for arsenic toxicology$396,412
R01 · FY2025 · ES
Role and Mitigation of Inflammasomes and Inflammation During COVID-19$619,067
R01 · FY2024 · AI
Humanized mouse models for arsenic toxicology$399,771
R01 · FY2024 · ES
Modeling the contribution of coronavirus cellular tropism to viral pathogenesis$194,375
R21 · FY2024 · AI · contact PI
Role and Mitigation of Inflammasomes and Inflammation During COVID-19$620,359
R01 · FY2023 · AI
Humanized mouse models for arsenic toxicology$410,118
R01 · FY2023 · ES
Modeling the contribution of coronavirus cellular tropism to viral pathogenesis$233,250
R21 · FY2023 · AI · contact PI
Role and Mitigation of Inflammasomes and Inflammation During COVID-19$571,427
R01 · FY2022 · AI
Humanized mouse models for arsenic toxicology$418,152
R01 · FY2022 · ES
Mouse models for study of the NLRP1 and CARD8 inflammasomes$194,375
R21 · FY2022 · AI · contact PI
Role and Mitigation of Inflammasomes and Inflammation During COVID-19$768,215
R56 · FY2021 · AI
Humanized mouse models for arsenic toxicology$438,897
R01 · FY2021 · ES
Mouse models for study of the NLRP1 and CARD8 inflammasomes$233,250
R21 · FY2021 · AI · contact PI
Genetically humanized mice for modeling human Fc-receptor interaction during influenza infection$194,375
R21 · FY2021 · AI · contact PI
Genetically humanized mice for modeling human Fc-receptor interaction during influenza infection$233,250
R21 · FY2020 · AI · contact PI
A humanized mouse model for arsenic toxicology$233,250
R21 · FY2019 · ES
A humanized mouse model for arsenic toxicology$194,375
R21 · FY2018 · ES
Genetic factors that regulate innate immunity$333,000
R01 · FY2016 · AR · contact PI
Modeling the role of DNA variants in the pathogenesis of lung disease$374,300
R01 · FY2015 · HL · contact PI
Genetic factors that regulate innate immunity$333,000
R01 · FY2015 · AR · contact PI
Assembly of disease-relevant pathways in the mouse$186,200
R21 · FY2015 · OD · contact PI
Model for evaluation of FCGR variants in disease and response to therapeutics$186,200
R21 · FY2015 · OD · contact PI
Modeling the role of DNA variants in the pathogenesis of lung disease$372,400
R01 · FY2014 · HL · contact PI
Genetic Determinants of Lung Injury$362,600
R01 · FY2014 · HL · contact PI
Genetic factors that regulate innate immunity$326,340
R01 · FY2014 · AR · contact PI
Assembly of disease-relevant pathways in the mouse$228,000
R21 · FY2014 · OD · contact PI
Model for evaluation of FCGR variants in disease and response to therapeutics$228,000
R21 · FY2014 · OD · contact PI
UDP-Glucuronosyltransferases in responses to environmental and endogenous toxins$180,675
R21 · FY2014 · ES · contact PI
Modeling the role of DNA variants in the pathogenesis of lung disease$361,760
R01 · FY2013 · HL · contact PI
Genetic Determinants of Lung Injury$352,240
R01 · FY2013 · HL · contact PI
Genetic factors that regulate innate immunity$316,350
R01 · FY2013 · AR · contact PI
UDP-Glucuronosyltransferases in responses to environmental and endogenous toxins$235,300
R21 · FY2013 · ES · contact PI
Modeling the role of DNA variants in the pathogenesis of lung disease$380,000
R01 · FY2012 · HL · contact PI
Genetic Determinants of Lung Injury$370,000
R01 · FY2012 · HL · contact PI
Genetic factors that regulate innate immunity$333,000
R01 · FY2012 · AR · contact PI
P2X7 and the Inflammasome Pathways in Lung Inflammation$308,209
U19 · FY2012 · AI · contact PI
Modeling proteostatic deficiencies in CFTR$222,000
R21 · FY2012 · HL · contact PI
Models for?functional evaluation of?CHRN polymorphisms$185,000
R21 · FY2012 · DA · contact PI
Genetic Determinants of Lung Injury$370,000
R01 · FY2011 · HL · contact PI
Characterization of Asthma Associated Polymorphisms$370,000
R01 · FY2011 · HL · contact PI
P2X7 and the Inflammasome Pathways in Lung Inflammation$295,270
U19 · FY2011 · AI · contact PI
Functional consequences of RAS polymorphisms$222,000
R21 · FY2011 · HL · contact PI
Models for?functional evaluation of?CHRN polymorphisms$222,000
R21 · FY2011 · DA · contact PI
Modeling proteostatic deficiencies in CFTR$185,000
R21 · FY2011 · HL · contact PI
Genetic factors in IgE-mediated food allergies$183,150
R21 · FY2011 · AI · contact PI
Contribution of Cis-acting Regulatory Polymorphisms to Psychiatric Disorders$500,000
RC1 · FY2010 · MH · contact PI
Characterization of Asthma Associated Polymorphisms$370,000
R01 · FY2010 · HL · contact PI
GST alleles and oxidant pollutants in the pathogenesis of asthma$370,000
R21 · FY2010 · HL · contact PI
P2X7 and the Inflammasome Pathways in Lung Inflammation$349,152
U19 · FY2010 · AI · contact PI
Functionally Significant Polymorphisms in Serotonin Pathway Genes$222,000
R33 · FY2010 · MH · contact PI
Genetic factors in IgE-mediated food allergies$222,000
R21 · FY2010 · AI · contact PI
Functional consequences of RAS polymorphisms$185,000
R21 · FY2010 · HL · contact PI
Contribution of Cis-acting Regulatory Polymorphisms to Psychiatric Disorders$500,000
RC1 · FY2009 · MH · contact PI
Characterization of Asthma Associated Polymorphisms$370,000
R01 · FY2009 · HL · contact PI
GST alleles and oxidant pollutants in the pathogenesis of asthma$370,000
R21 · FY2009 · HL · contact PI
Eicosanoids and GPCRs in Airway Physiology$352,796
R01 · FY2009 · HL · contact PI
PGE2 in the Pathogenesis of Allergic Airway Disease$344,597
R01 · FY2009 · HL · contact PI
P2X7 and the Inflammasome Pathways in Lung Inflammation$304,435
U19 · FY2009 · AI · contact PI
PROSTANOID PATHWAYS IN ALLOGRAFT REJECTION$252,612
P01 · FY2009 · DK · contact PI
Functionally Significant Polymorphisms in Serotonin Pathway Genes$147,917
R21 · FY2009 · MH · contact PI
Characterization of Asthma Associated Polymorphisms$368,750
R01 · FY2008 · HL · contact PI
Eicosanoids and GPCRs in Airway Physiology$352,796
R01 · FY2008 · HL · contact PI
PGE2 in the Pathogenesis of Allergic Airway Disease$344,597
R01 · FY2008 · HL · contact PI
P2X7 and the Inflammasome Pathways in Lung Inflammation$298,983
U19 · FY2008 · AI · contact PI
PROSTANOID PATHWAYS IN ALLOGRAFT REJECTION$252,612
P01 · FY2008 · DK · contact PI
Functionally Significant Polymorphisms in Serotonin Pathway Genes$147,250
R21 · FY2008 · MH · contact PI
Eicosanoids and GPCRs in Airway Physiology$352,796
R01 · FY2007 · HL · contact PI
Na-K-CI Cotransport in Pathogenesis of Airway Disease$345,429
R01 · FY2007 · HL · contact PI
Role of Onzin, a defensin like molecule, in lung disease$345,429
R01 · FY2007 · HL · contact PI
PGE2 in the Pathogenesis of Allergic Airway Disease$344,597
R01 · FY2007 · HL · contact PI
PROSTANOID PATHWAYS IN ALLOGRAFT REJECTION$229,666
P01 · FY2007 · DK · contact PI
Eicosanoids and GPCRs in Airway Physiology$363,333
R01 · FY2006 · HL · contact PI
Na-K-CI Cotransport in Pathogenesis of Airway Disease$355,746
R01 · FY2006 · HL · contact PI
Role of Onzin, a defensin like molecule, in lung disease$355,746
R01 · FY2006 · HL · contact PI
PGE2 in the Pathogenesis of Allergic Airway Disease$354,889
R01 · FY2006 · HL · contact PI
PROSTANOID PATHWAYS IN ALLOGRAFT REJECTION$242,217
P01 · FY2006 · DK · contact PI
Na-K-CI Cotransport in Pathogenesis of Airway Disease$364,307
R01 · FY2005 · HL
Role of Onzin, a defensin like molecule, in lung disease$364,307
R01 · FY2005 · HL
PGE2 in the Pathogenesis of Allergic Airway Disease$363,430
R01 · FY2005 · HL
PROSTANOID PATHWAYS IN ALLOGRAFT REJECTION$251,167
P01 · FY2005 · DK
Prostanoids and their receptors in asthma$158,638
P50 · FY2005 · HL
Role of Onzin, a defensin like molecule, in lung disease$364,307
R01 · FY2004 · HL
Na-K-CI Cotransport in Pathogenesis of Airway Disease$364,307
R01 · FY2004 · HL
PGE2 in the Pathogenesis of Allergic Airways Disease$363,750
R01 · FY2004 · HL
VASCULAR REMODELING: THE DUCTUS ARTERIOSUS MODEL$291,000
R01 · FY2004 · HL
PGE2 in the Pathogenesis of Allergic Airways Disease$363,750
R01 · FY2003 · HL
VASCULAR REMODELING: THE DUCTUS ARTERIOSUS MODEL$291,000
R01 · FY2003 · HL
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS$215,802
R01 · FY2003 · CA
PGE2 in the Pathogenesis of Allergic Airways Disease$363,750
R01 · FY2002 · HL
VASCULAR REMODELING: THE DUCTUS ARTERIOSUS MODEL$291,000
R01 · FY2002 · HL
ROLE OF LEUKOTRIENES IN IMMUNE RESPONSES$259,264
P01 · FY2002 · DK
CHLORIDE TRANSPORT IN MOUSE AIRWAYS$243,516
P50 · FY2002 · HL
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS$209,516
R01 · FY2002 · CA
CORE--GENE TARGETING$157,506
P30 · FY2002 · CA
Prostanoids and their receptors in asthma$145,839
P50 · FY2002 · HL
PGE2 in the Pathogenesis of Allergic Airways Disease$363,750
R01 · FY2001 · HL
VASCULAR REMODELING: THE DUCTUS ARTERIOSUS MODEL$290,500
R01 · FY2001 · HL
ROLE OF LEUKOTRIENES IN IMMUNE RESPONSES$259,264
P01 · FY2001 · DK
CHLORIDE TRANSPORT IN MOUSE AIRWAYS$243,516
P50 · FY2001 · HL
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS$203,414
R01 · FY2001 · CA
CORE--GENE TARGETING$158,272
P30 · FY2001 · CA
CORE--GENE TARGETING$157,506
P30 · FY2001 · CA
PGE2 AND REGULATION OF AIRWAY EPITHELIUM$280,782
R01 · FY2000 · HL
ROLE OF LEUKOTRIENES IN IMMUNE RESPONSES$259,264
P01 · FY2000 · DK
CORE--MOUSE FACILITY$254,634
P01 · FY2000 · HL
CHLORIDE TRANSPORT IN MOUSE AIRWAYS$222,562
P50 · FY2000 · HL
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS$197,488
R01 · FY2000 · CA
ROLE OF LEUKOTRIENES IN IMMUNE RESPONSES$180,960
P01 · FY2000 · DK
CORE--GENE TARGETING$0
P30 · FY2000 · CA
CORE--GENE TARGETING$0
P30 · FY2000 · CA